Levosimendan to Facilitate Weaning From ECMO in Patients With Severe Cardiogenic Shock
This study aimed to determine if early levosimendan administration shortens the time to successful weaning from venoarterial extracorporeal membrane oxygenation (VA-ECMO) in adult patients with severe, potentially reversible cardiogenic shock.
Publication Details
- Journal
- JAMA
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1001/jama.2025.22261
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 0.00